Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$56.27 - $73.77 $13,054 - $17,114
-232 Reduced 2.32%
9,787 $675,000
Q4 2023

Feb 09, 2024

SELL
$59.06 - $75.72 $59,060 - $75,720
-1,000 Reduced 9.08%
10,019 $741,000
Q3 2023

Nov 01, 2023

SELL
$65.94 - $99.04 $3.77 Million - $5.66 Million
-57,102 Reduced 83.82%
11,019 $751,000
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $23,003 - $34,883
-367 Reduced 0.54%
68,121 $6.4 Million
Q1 2023

Aug 30, 2023

BUY
$47.19 - $70.77 $17,318 - $25,972
367 Added 0.54%
68,488 $4.64 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $3.23 Million - $4.85 Million
68,488 New
68,488 $4.64 Million
Q3 2020

Nov 13, 2020

SELL
$72.92 - $102.01 $5,760 - $8,058
-79 Closed
0 $0
Q2 2020

Aug 19, 2020

SELL
$55.75 - $92.75 $4,014 - $6,678
-72 Reduced 47.68%
79 $7,000
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $2,539 - $6,997
67 Added 79.76%
151 $9,000
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $6,523 - $8,378
84 New
84 $8,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.